Fig. 4

Kaplan–Meier stratified by combination of plakoglobin and E-cadherin expression in breast cancer. Compared with those with high plakoglobin and low E-cadherin expression, patients with others had superior overall survival (P < 0.001) (c), disease-free survival (P < 0.001) (b), and distant-metastasis-free survival (P < 0.001) (a)